Synbio News

March 20, 2010

Would You Pay $20 for Access to a Breast Cancer Cure?

The New York Times

The Pink Army Cooperative is selling $20 shares in a journey toward a personalized cure for breast cancer. This Canadian organization has set out to lower the cost of cancer treatments while also making them more effective by embracing a new wave of synthetic biology technology.

http://bits.blogs.nytimes.com/2010/03/20/would-you-pay-20-for-access-to-a-breast-cancer-cure/?ref=technology